Cargando…

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine

Chemoresistance is the major impediment for treating pancreatic cancer. Herb-derived compound triptolide (TP) can inhibit proliferation of chemo-resistant pancreatic cancer (CPC) cell lines through multiple mechanisms, which exhibited superior anticancer efficacy compared with gemcitabine. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Cheng, Liu, Biao, Xu, Xuelian, Zhuang, Bo, Li, Hongxia, Yin, Jiaqi, Cong, Mengyi, Xu, Wei, Lu, Aiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884998/ https://www.ncbi.nlm.nih.gov/pubmed/26840019 http://dx.doi.org/10.18632/oncotarget.7073

Ejemplares similares

Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine
por: Sun, Rui, et al.
Publicado: (2022)

Towards feedback-controlled nanomedicines for smart, adaptive delivery
por: Jones, Stephen J., et al.
Publicado: (2018)

The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation
por: Fan, Danping, et al.
Publicado: (2018)

Hydroxyethyl starch based smart nanomedicine
por: Wang, Huimin, et al.
Publicado: (2021)

Special Issue on Cancer Smart Nanomedicine
por: Pinheiro, Marina, et al.
Publicado: (2023)

TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment
por: Wang, Xinlong, et al.
Publicado: (2022)

A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin
por: Li, Yuanpei, et al.
Publicado: (2014)

Smart pH-responsive nanomedicines for disease therapy
por: Shinn, Jongyoon, et al.
Publicado: (2022)

A review of the total syntheses of triptolide
por: Zhang, Xiang, et al.
Publicado: (2019)

Public optimism towards nanomedicine
por: Bottini, Massimo, et al.
Publicado: (2011)

Catalytic Asymmetric Formal Total Synthesis of (−)-Triptophenolide and (+)-Triptolide
por: Xu, Wen-Dan, et al.
Publicado: (2016)

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines
por: Rinaldi, Arianna, et al.
Publicado: (2022)

Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts
por: Noel, Pawan, et al.
Publicado: (2020)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
por: Brachi, Giulia, et al.
Publicado: (2019)

Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis
por: Fan, Danping, et al.
Publicado: (2016)

A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia
por: Datan, Emmanuel, et al.
Publicado: (2020)

Recent progress in nanomedicine for enhanced cancer chemotherapy
por: Wei, Guoqing, et al.
Publicado: (2021)

Smart H(2)S‐Triggered/Therapeutic System (SHTS)‐Based Nanomedicine
por: Chen, Weiyu, et al.
Publicado: (2019)

Smart Vitamin Micelles as Cancer Nanomedicines for Enhanced Intracellular Delivery of Doxorubicin
por: Ko, Na Re, et al.
Publicado: (2021)

Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
por: Ortíz, Raúl, et al.
Publicado: (2021)

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
por: Greene, Michelle K., et al.
Publicado: (2021)

Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice
por: Kong, Ling-Lei, et al.
Publicado: (2015)

Effect of the Natural Product Triptolide on Pancreatic Cancer: A Systematic Review of Preclinical Studies
por: Zhang, Chi, et al.
Publicado: (2017)

Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line
por: Kim, Seung Tae, et al.
Publicado: (2018)

Smart Materials Meet Multifunctional Biomedical Devices: Current and Prospective Implications for Nanomedicine
por: Genchi, Giada Graziana, et al.
Publicado: (2017)

Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
por: Olver, Ian, et al.
Publicado: (2007)

Inhaled chemotherapy in lung cancer: future concept of nanomedicine
por: Zarogoulidis, Paul, et al.
Publicado: (2012)

Nanomedicine-enabled chemotherapy-based synergetic cancer treatments
por: Wu, Wencheng, et al.
Publicado: (2022)

Effects Of Triptolide On Tooth Movement And Root Resorption In Rats
por: Yang, Fan, et al.
Publicado: (2019)

Innate and adaptive immune responses toward nanomedicines
por: Viana, Iara Maíra de Oliveira, et al.
Publicado: (2021)

Effects of puerarin on the pharmacokinetics of triptolide in rats
por: Wang, Qingfa, et al.
Publicado: (2019)

The molecular pathogenesis of triptolide-induced hepatotoxicity
por: Hu, Yeqing, et al.
Publicado: (2022)

Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2018)

Preparation and Optimization of Triptolide-Loaded Solid Lipid Nanoparticles for Oral Delivery with Reduced Gastric Irritation
por: Zhang, Cong, et al.
Publicado: (2013)

NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy
por: Zhao, Pengfei, et al.
Publicado: (2015)

Sonocatalytic Optimization of Titanium‐Based Therapeutic Nanomedicine
por: Zhou, Ruirui, et al.
Publicado: (2023)

Dendritic cell combination therapy reduces the toxicity of triptolide and ameliorates colitis in murine models
por: Rao, Quan, et al.
Publicado: (2022)

Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases—A Review
por: Yuan, Kai, et al.
Publicado: (2019)

MicroRNAs as crucial mediators in the pharmacological activities of triptolide (Review)
por: Zhou, Kun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ij34vjk25lq15fg35jvqpuact8